EVALUATION OF TROUGH LEVEL AND DISEASE ACTIVITY AFTER SWITCH FROM ADALIMUMAB ORIGINATOR TO BIOSIMILAR IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Nele Deprez 1
Thomas De Somer 1
Didier Baert 1
Mieke Deceuninck 2
Inge Huys 1
Veerle Mattens 3
An Sterckx 3
Stijn Vanden Branden 3
Erik Vanderstraeten 1
Jo Vandervoort 3
Nina Van Heddegem 1
Pieter Dewint 1
1 AZ Maria Middelares Gent, Gent, Belgium
2 Sint Vincentius Ziekenhuis Deinze, Deinze, Belgium
3 OLV Ziekenhuis Aalst, Aalst, Belgium
Session
IBD (Posters)
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]